No profile data available.
GH Research PLC (GHRS) is a healthcare company in the brain and nerve treatment drugs industry, based in Dublin, Ireland, with about 73 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$48.26 million. Its market capitalization was $1.45 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.
GH Research reported $0 in revenue for fiscal year 2025.
$1.45 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (brain and nerve treatment drugs) include Rapport Therapeutics, Inc. (RAPP), Taysha Gene Therapies, Inc. (TSHA), Mind Medicine (MindMed) Inc. (MNMD), LB Pharmaceuticals Inc (LBRX).